Sage Journals: Discover world-class research

Retricted access

Research article

First published 2021-7

The effect of tonsillectomy on John Cunningham virus serological status in multiple sclerosis patients: A retrospective case–control study

Mirla Avila, Annette Okai, Smathorn Thakolwiboon [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2018-7

High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis

Alexander Lau, Wei Qiu, Allan Kermode [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2021

Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome in seven patients with sarcoidosis: a critical discussion of treatment and prognosis

Maike F. Dohrn, Gisa Ellrichmann, Rastislav Pjontek [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2021

High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients

Christopher M. Dwyer, Vilija G. Jokubaitis, Jim Stankovich [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2021-10

The results of a 24-month controlled,prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy,who switched from prolonged use of natalizumab to teriflunomide

Stanley Cohan, Tiffany Gervasi-Follmar, Aneesh Kamath [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2024-6

The impact of social distancing measures on anti–JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis

Stephen C Krieger, Susie Sinks, Furong Huang [...]

Multiple Sclerosis Journal

Free access

Case report

First published 2017-11

Progressive Multifocal Leukoencephalopathy due to John Cunningham (JC) virus following Allogeneic Haematopoietic Cell Transplantation

Wilson Lam, Zeyad Al-Shaibani, Deepali Kumar [...]

Antiviral Therapy

Retricted access

Review article

First published 2018-4

Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters

Nicholas Schwab, Tilman Schneider-Hohendorf, Tammy Hoyt [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2023-10

Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients

Auli Verkkoniemi-Ahola, Päivi Hartikainen, Katja Hassi [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Letter

First published 2020-1

Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders

Shinji Aoyama, Masahiro Mori, Akiyuki Uzawa [...]

Multiple Sclerosis Journal

Search results